TB500 (Thymosin B4 Acetate) Explained: What "Acetate" Means and Why It's on the Label
BPC-157 + TB500 Pack 5mg + 5mg
Same Peptide, More Precise Label
TB500 and TB-500 both refer to the same synthetic 17-amino-acid fragment built around the LKKTETQ actin-binding motif of Thymosin Beta-4. Adding "(Thymosin B4 Acetate)" to the product name does not describe a different compound — it specifies the salt form the peptide is supplied in, which is a standard piece of information on a research-grade peptide label alongside sequence, molecular weight, and purity.
What a Peptide "Salt Form" Actually Is
Synthetic peptides are built through solid-phase synthesis and then cleaved, purified, and typically lyophilised (freeze-dried) into a stable powder. During this process the peptide chain — which carries both positively and negatively charged sites along its amino acid backbone — associates with counter-ions to form a stable salt. Acetate (the ion derived from acetic acid) is one of the most common counter-ions used across the synthetic peptide research industry generally, alongside alternatives like trifluoroacetate (TFA) and hydrochloride.
The choice of salt form is a synthesis and formulation detail, not a change to the peptide's amino acid sequence or its identity. Two vials of the same peptide sequence supplied as different salt forms contain the same active molecule; the salt form affects handling properties like aqueous solubility and lyophilisation stability, not what the sequence is.
Why acetate specifically is widely used
- Aqueous solubility. Acetate salt forms are generally well-suited to dissolving cleanly in aqueous solutions such as bacteriostatic water, a property relevant to laboratory reconstitution.
- Lyophilisation stability. Acetate-form peptides are commonly reported in peptide chemistry literature as forming stable, well-characterised lyophilised powders.
- Lower residual counter-ion concerns. Compared to alternatives like TFA salts — which some research contexts flag as potentially interfering with certain bioassay readouts — acetate is often the preferred default for research-grade material precisely because it is considered less likely to introduce that kind of confound.
How This Relates to HPLC Purity Verification
High-performance liquid chromatography (HPLC) purity testing measures what proportion of the material in a vial is the correctly-synthesized target peptide sequence, versus truncated fragments, deletion sequences, or other synthesis by-products. This measurement is reported independently of the salt form — a purity result of ≥98.8%, for example, describes the sequence-purity of the peptide itself, with the counter-ion contributing to the total lyophilised mass but not counted against the sequence-purity figure.
REVIVE LAB UAE provides a lot-level certificate of analysis (COA) with HPLC purity data for every TB500 vial shipped, so UAE researchers can independently verify sequence identity and purity rather than relying on the label alone.
TB500 (Thymosin B4 Acetate) Vial Specifications at REVIVE LAB UAE
| Spec | BPC-157 + TB500 pack (5 mg + 5 mg) |
|---|---|
| Form | Lyophilised powder |
| Sequence | Thymosin Beta-4 fragment, 17 amino acids (LKKTETQ actin-binding motif) |
| Salt form | Acetate |
| Molecular weight | ≈1880 Da |
| Purity (HPLC) | ≥98.8% |
| Reconstitution | Bacteriostatic water, 2–3 mL (concentration math only, not administration guidance) |
| Storage (lyophilised) | −20°C, desiccated |
| Labelling | Research Use Only — not for human or veterinary use |
| Price | AED 510 |
HPLC-verified, ≥98.8% purity, lot-level COA on every parcel. Sold strictly as a laboratory research reference material.
View TB500 product page →
Research Use Only — No Administration Guidance
REVIVE LAB UAE does not provide dosing, cycling, administration route, or scheduling guidance for TB500 or any other compound sold on this site — that determination sits entirely with the researcher's own institutional protocol. This article is a chemistry-labelling explainer, not medical advice, and should not be read as a recommendation for use in any living organism.
References
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opin Biol Ther. 2012;12(1):37-51.
- Crockford D, Turjman N, Allan C, Angel J. Thymosin β4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010;1194:179-189.
- Low TL, Goldstein AL. Chemical characterization of Thymosin Beta-4, a thymic peptide isolated from calf thymosin fraction.